Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-26-025929
Filing Date
2026-08-05
Accepted
2026-08-05 16:16:33
Documents
1
Period of Report
2026-08-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 5330
  Complete submission text file 0001437749-26-025929.txt   6766
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address
Foster Jonathan P. (Reporting) CIK: 0001545414 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37758 | Film No.: 261243790

Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Issuer) CIK: 0001659617 (see all company filings)

EIN.: 474671997 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)